Rahul Garella
Director/Board Member chez Par Formulations Pvt Ltd.
Profil
Rahul Garella is currently a Director at Auxilium UK Ltd.
and Par Formulations Pvt Ltd.
He is also the Executive Vice President at International Pharmaceuticals, Inc. since 2019.
Previously, he was the SVP-Head of International Pharmaceuticals at Endo International Plc from 2016 to 2019.
He was also the Senior Vice President at Glenmark Pharmaceuticals Ltd.
from 2008 to 2014 and at Glenmark Pharmaceuticals Europe Ltd.
from 2008 to 2014.
Additionally, he served as the Chief Commercial Officer-International Markets at Strides Pharma Science Ltd.
Mr. Garella holds an MBA from the Institute of Management Technology and an undergraduate degree from Jamia Millia Islamia.
Postes actifs de Rahul Garella
| Sociétés | Poste | Début |
|---|---|---|
Par Formulations Pvt Ltd.
 Par Formulations Pvt Ltd. Pharmaceuticals: MajorHealth Technology Par Formulations Pvt Ltd. manufactures pharmaceutical products. The firm develops, manufacturers and distributes generics pharmaceutical products. It offers facilities for manufacturing, packing of liquids and semi-solids as well as solid dose products. The company was founded in 1978 and is headquartered in Chennai, India. | Director/Board Member | - |
Auxilium UK Ltd.
 Auxilium UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Endo International Plc, Auxilium UK Ltd. develops and markets pharmaceutical products. The private company is based in London, UK. Auxilium was founded in 2000. | Director/Board Member | 01/02/2018 |
International Pharmaceuticals, Inc.
 International Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology International Pharmaceuticals, Inc. is a Filipino company that manufactures pharmaceutical products. | Corporate Officer/Principal | 01/08/2019 |
Anciens postes connus de Rahul Garella
| Sociétés | Poste | Fin |
|---|---|---|
| STRIDES PHARMA SCIENCE LIMITED | Corporate Officer/Principal | 01/03/2022 |
Glenmark Pharmaceuticals Europe Ltd.
 Glenmark Pharmaceuticals Europe Ltd. Pharmaceuticals: MajorHealth Technology Part of Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals Europe Ltd. is a British pharmaceutical company that is discovering advanced therapies for dermatology, oncology, and inflammation. Founded in 2004, the private company is based in Harrow, UK. Glenmark's R&D is committed to identifying products that fulfill unique and unmet medical needs. The company began its operations in the market of exporting branded formulations to countries and provides financial results, announcements, and reports for investors and shareholders. | Corporate Officer/Principal | 01/01/2014 |
| GLENMARK PHARMACEUTICALS LIMITED | Corporate Officer/Principal | 01/01/2014 |
| ENDO INTERNATIONAL PLC | Corporate Officer/Principal | - |
Formation de Rahul Garella
| Institute of Management Technology | Masters Business Admin |
| Jamia Millia Islamia | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GLENMARK PHARMACEUTICALS LIMITED | Health Technology |
| STRIDES PHARMA SCIENCE LIMITED | Health Technology |
| Entreprise privées | 5 |
|---|---|
Endo International Plc
 Endo International Plc Pharmaceuticals: MajorHealth Technology Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland. | Health Technology |
International Pharmaceuticals, Inc.
International Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology International Pharmaceuticals, Inc. is a Filipino company that manufactures pharmaceutical products. | Health Technology |
Glenmark Pharmaceuticals Europe Ltd.
Glenmark Pharmaceuticals Europe Ltd. Pharmaceuticals: MajorHealth Technology Part of Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals Europe Ltd. is a British pharmaceutical company that is discovering advanced therapies for dermatology, oncology, and inflammation. Founded in 2004, the private company is based in Harrow, UK. Glenmark's R&D is committed to identifying products that fulfill unique and unmet medical needs. The company began its operations in the market of exporting branded formulations to countries and provides financial results, announcements, and reports for investors and shareholders. | Health Technology |
Auxilium UK Ltd.
Auxilium UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Endo International Plc, Auxilium UK Ltd. develops and markets pharmaceutical products. The private company is based in London, UK. Auxilium was founded in 2000. | Health Technology |
Par Formulations Pvt Ltd.
Par Formulations Pvt Ltd. Pharmaceuticals: MajorHealth Technology Par Formulations Pvt Ltd. manufactures pharmaceutical products. The firm develops, manufacturers and distributes generics pharmaceutical products. It offers facilities for manufacturing, packing of liquids and semi-solids as well as solid dose products. The company was founded in 1978 and is headquartered in Chennai, India. | Health Technology |
